These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33660954)

  • 1. Nonalcoholic fatty liver disease - a growing public health problem.
    Mikolašević I; Filipec Kanižaj T; Targher G
    Croat Med J; 2021 Feb; 62(1):1-3. PubMed ID: 33660954
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease: An Expanding Health Care Epidemic.
    Bernstein DE
    Clin Liver Dis; 2018 Feb; 22(1):xiii-xiv. PubMed ID: 29128064
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonalcoholic hepatic steatosis: a silent disease].
    Aguilera-Méndez A
    Rev Med Inst Mex Seguro Soc; 2019 Mar; 56(6):544-549. PubMed ID: 30889343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic fatty liver disease: What do we know and what will we have to learn?].
    Volkova NI; Porksheyan MI
    Ter Arkh; 2017; 89(2):91-98. PubMed ID: 28393828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON).
    Kohli R; Sunduram S; Mouzaki M; Ali S; Sathya P; Abrams S; Xanthakos SA; Vos M; Schwimmer JB
    J Pediatr; 2016 May; 172():9-13. PubMed ID: 26749112
    [No Abstract]   [Full Text] [Related]  

  • 7. [Current Status and Future Prospects of Nonalcoholic Fatty Liver Disease (NAFLD) in Japan-Feedback from Clinical and Basic Researches to Medical Therapy and Pharmacist Activities].
    Tokuyama S; Kim KI
    Yakugaku Zasshi; 2016; 136(4):563. PubMed ID: 27040339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevalence of nonalcoholic fatty liver disease in young patients with abdominal obesity and hypertension].
    Chulkov VS; Sumerkina VA; Abramovskikh OS; Chulkov VS
    Eksp Klin Gastroenterol; 2014; (11):42-5. PubMed ID: 25842663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.
    Andronescu CI; Purcarea MR; Babes PA
    J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease.
    Sweet PH; Khoo T; Nguyen S
    Prim Care; 2017 Dec; 44(4):599-607. PubMed ID: 29132522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease and cardiovascular disease.
    Hyogo H; Chayama K; Yamagishi S
    Curr Pharm Des; 2014; 20(14):2403-11. PubMed ID: 23844815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic Fatty Liver Disease: A Silent Epidemic.
    Sivell C
    Gastroenterol Nurs; 2019; 42(5):428-434. PubMed ID: 31574071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Younossi ZM; Henry L; Bush H; Mishra A
    Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical importance of the nonalcoholic fatty liver disease: a review.
    Chumak AA; Ovsyannikova LM; Sarkisova EA; Gasanova EV
    Probl Radiac Med Radiobiol; 2013; (18):277-88. PubMed ID: 25191732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges.
    Cholankeril G; Perumpail RB; Pham EA; Ahmed A; Harrison SA
    Hepatology; 2016 Sep; 64(3):954. PubMed ID: 27388553
    [No Abstract]   [Full Text] [Related]  

  • 19. [Epidemiology of non-alcoholic steatohepatitis. Extent/burden of the problem and its impact on public health].
    Vallet-Pichard A; Parlati L; Pol S
    Presse Med; 2019 Dec; 48(12):1459-1467. PubMed ID: 31757728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [[The Modern View on Pathogenesis and Treatment of Nonalcoholic Fatty Liver Disease].].
    Podymova SD
    Eksp Klin Gastroenterol; 2016; (5):74-82. PubMed ID: 28614648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.